CAS: 17086-76-9; (3S,4S,5R)-4-((2R,3R)-2,3-Dihydroxy-3-((2S,3R,5R,9R,10R,13R,17S)-2,3,14-Trihydroxy-10,13-Dimethyl-6-Oxo-2,3,4,5,6,9,10,11,12,13,14,15,16,17-Tetradecahydro-1H-Cyclopenta[a]Phenanthren-17-yl)Butyl)-5-Hydroxy-3-Methyltetrahydro-2H-Pyran-2-One

英文名称(3S,4S,5R)-4-((2R,3R)-2,3-Dihydroxy-3-((2S,3R,5R,9R,10R,13R,17S)-2,3,14-Trihydroxy-10,13-Dimethyl-6-Oxo-2,3,4,5,6,9,10,11,12,13,14,15,16,17-Tetradecahydro-1H-Cyclopenta[a]Phenanthren-17-yl)Butyl)-5-Hydroxy-3-Methyltetrahydro-2H-Pyran-2-One
中文名称杯苋甾酮
IUPAC名称(3S,4S,5R)-4-((2R,3R)-2,3-dihydroxy-3-((2S,3R,5R,9R,10R,13R,17S)-2,3,14-trihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,6,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)butyl)-5-hydroxy-3-methyltetrahydro-2H-pyran-2-one
其它别名5b-Stigmast-7-en-26-oic acid, 2b,3b,14,20,22,28-hexahydroxy-6-oxo-, g-lactone, (22R,24S,25S,28R)-(8CI); Cyasteron; Cyasterone
CAS编号17086-76-9
MFCD编号:MFCD26960928
EINECS号:683-195-0
FDA UNII编号:VWR78EE33V
分子式:C29H44O9
分子量:536.66
产品CID: 876076
产品分类生物化工 → 提取物

相似结构搜索
产品信息参考;;;;
InChIKey: NEFYSBQJYCICOG-YSEUJXISSA-N
InChI=1S/C29H44O9/c1-14-15(22(33)13-38-25(14)35)9-24(34)28(4,36)23-6-8-29(37)17-10-19(30)18-11-20(31)21(32)12-26(18,2)16(17)5-7-27(23,29)3/h…
计算化学: 氢键受体数8.0氢键供体数5.0可旋转键数4.0

物理性质

熔点164～166°C
沸点742.8±60.0 °C at 760 mmHg
闪点242.0±26.4 °C
密度1.3±0.1 g/cm3
pKa:14.12±0.70(预测)
PSA:144.52
LogP:-0.25
折射率1.600
蒸汽压0.0±5.6 mmHg at 25°C
溶解性Soluble In Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,Etc.
外观形态白色至类白色粉末
储存条件在惰性气体(氮气或氩气)下 2–8 °C
产品应用该化合物用作内容确定,识别和药理研究; 也显示出药理活动,包括养血,松绑,驱散风和去除潮湿.

MSDS等安全信息

GHS象形图
GHS符号GHS07;
注释: Exclamation mark
危险类别急性毒性类别4(经口)
警示词Warning(警告)
危险描述H302 |吞咽有害.
防范说明P501-P240-P210-P233-P243-P241-P242-P264-P280-P370+P378-P303+P361+P353-P301+P330+P331-P363-P304+P340+P310-P305+P351+P338+P310-P403+P235-P405
UN编号NONH for all modes of transport
安全声明24/25
WGK Germany3

欧盟法规

C&L通报

合成工艺路线路线简述

海关参考信息

2901210000-乙烯
2901220000-丙烯
2905122000-异丙醇
2905143000-叔丁醇
💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
详情请参考：📖 海关编码查询和海关进出口税则

专利信息

专利号:US-9700589-B2
优先权日:2015-02-03
标题:Compositions and methods for improved muscle metabolism
发明人：BILY ANTOINE CHARLES; MEYER MARJOLAINE; CHEVALIER KARL; LaurenÃ§on Lise; FEUILLERE NICOLAS; ROLLER MARC; BIRTIC SIMONA
权利人:NATUREX SA
摘要:A composition for improving muscle metabolism in a subject and methods for manufacturing and using same. Embodiments include compositions having an extract of Rhaponticum and an extract of Rhodiola . An extract of Rhaponticum may include amounts of ecdysterones including 20-hydroxyecdysone. An extract of Rhodiola my include salidrosides and rosavins, including rosavin. Suitable ingestion dosages of the composition may be operable to increase protein synthesis and reduce protein proteolysis in a subject.